World Of Taxonomy
0131-1810Level 3

Vimpat (lacosamide)

**Product type:** Human Prescription Drug

**Active ingredient:** LACOSAMIDE

**Strength:** 10 mg/mL

**Dosage form:** Injection

**Route:** Intravenous

**Labeler:** UCB, Inc.

**Marketing category:** NDA (NDA022254)

**Pharmacologic class:** Decreased Central Nervous System Disorganized Electrical Activity [PE]

**DEA schedule:** CV

GET/api/v1/systems/ndc_fda/nodes/0131-1810
Official DownloadPublic Domain (US Government)Source

Hierarchy Explorer

Loading...

Cross-system equivalences0

No cross-system equivalences mapped for this node.